Latest Order Book News

CurveBeam AI has reported a record quarter for HiRise™ device purchase orders, driven by a strategic expansion with Stryker in Australia and New Zealand. The company also advanced its FDA regulatory pathway for its BMD module, setting sights on mid-2025 submission.

Hydrix Limited reports back-to-back profitable quarters driven by strong margins and cost efficiencies, underpinned by a robust $40 million sales opportunity pipeline in cardiac and medtech sectors.

ECS Botanics reports a striking 339% quarter-on-quarter growth in its B2C sales, offsetting a slight dip in total revenue as it pivots to a hybrid B2B and B2C business model. The company’s record harvest and new product launches position it for a promising turnaround.

Veris Limited has reported a remarkable 212% increase in profit before tax for H1 FY25, driven by a strategic pivot towards higher-margin projects and successful restructuring efforts. Despite a slight revenue dip, the company’s strong order book and cash position signal robust growth potential.

Bioxyne Limited has raised its FY2025 revenue forecast to $25 million, driven by a remarkable 267% increase in first-half revenue and strong momentum from its subsidiary Breathe Life Sciences.

FleetPartners Group Limited reported a strong FY24 with record new business writings and a significant capital return, underscoring its disciplined growth and ESG commitments.

Korvest Ltd’s first half of FY25 saw profitability pressures from operational setbacks and inflation, but a record order book and new major projects set the stage for a promising second half.

Korvest Ltd reported a 1.1% decline in revenue and a sharp 28.5% drop in net profit for the half-year ending December 2024, impacted by operational disruptions and competitive pressures. Despite these challenges, the company anticipates a robust rebound in project activity in the second half of FY25.

Macmahon Holdings has landed a $463 million mining services contract for the Awak Mas gold project in Indonesia, reinforcing its order book and maintaining its FY25 earnings guidance.